<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03419546</url>
  </required_header>
  <id_info>
    <org_study_id>EO 131/2017_FJD</org_study_id>
    <nct_id>NCT03419546</nct_id>
  </id_info>
  <brief_title>Clinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)</brief_title>
  <official_title>Clinical Validation Trial of the Single-use Bronchoscope Ambu® aScope ™ 4</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ambu A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the usefulness of the new Ambu® aScope ™ 4 bronchoscope,
      in the usual practice of low complexity diagnostic bronchoscopy managed by bronchoscopists
      who meet the minimum training requirements (having performed 100 supervised procedures [ 10])
      and maintenance of competition (with more than 25 bronchoscopies per year [10]).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muticentric trial to evaluate three outcomes

        1. Describe the experience of bronchoscopists performing low complexity bronchoscopic
           procedures with the Ambu® aScope ™ 4.

        2. Collect the opinion of bronchoscopists about the technical characteristics of the device
           subject to study through a standardized questionnaire.

        3. Analyze the quality of both microbiological and cytological samples obtained through the
           disposable bronchoscope.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">August 31, 2018</completion_date>
  <primary_completion_date type="Actual">August 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bronchoscope Quality questionnaire evaluation</measure>
    <time_frame>Feb 2018- july 2018</time_frame>
    <description>- A numeric scale describes the experience of bronchoscopists performing low complexity bronchoscopic procedures with the Ambu® aScope ™ 4.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>-Opinion of the operator -Quality of the sample</measure>
    <time_frame>Feb 2018 -july 2018</time_frame>
    <description>1.A numeric scale collects the opinion of bronchoscopists about the technical characteristics of the device subject to study through a standardized questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Sample quality</measure>
    <time_frame>Feb 2018- july 2018</time_frame>
    <description>2.Analyze the quality of both microbiological and cytological samples obtained through the disposable bronchoscope describing the diagnostic yield.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">216</enrollment>
  <condition>Bronchoscopy</condition>
  <arm_group>
    <arm_group_label>Bronchoscopic procedures</arm_group_label>
    <description>Bronchoscopies performed in different sites to evaluate the level of satisfaction of the operators with the device Ambu® aScope™ 4</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bronchoscopic lavage with cell analysis
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        - Patients that require a low complexity bronchoscopy that accept the informed consent
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Low complexity bronchoscopies in patients that need to undergo a low complexity
             bronchoscopy in the sites of the study

        Exclusion Criteria:

          -  No acceptance of the informed consent

          -  Any procedure out of a low complexity bronchoscopy in the sites of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Javier Flandes</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fundacion Jimenez Diaz</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>January 19, 2018</study_first_submitted>
  <study_first_submitted_qc>January 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2018</study_first_posted>
  <last_update_submitted>October 17, 2018</last_update_submitted>
  <last_update_submitted_qc>October 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

